Publications by authors named "Noopur S Raje"

42Publications

Phase 1 study of the anti-BCMA antibody-drug conjugate AMG 224 in patients with relapsed/refractory multiple myeloma.

Leukemia 2020 Apr 21. Epub 2020 Apr 21.

Malignant Haematology & Stem Cell Transplantation Service, The Alfred Hospital, Monash University, Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41375-020-0834-9DOI Listing
April 2020

Successful anti-CD19 CAR T-cell therapy in HIV-infected patients with refractory high-grade B-cell lymphoma.

Cancer 2019 Nov 10;125(21):3692-3698. Epub 2019 Sep 10.

Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32411DOI Listing
November 2019

BRAF Inhibition in -Mutant Gliomas: Results From the VE-BASKET Study.

J Clin Oncol 2018 12 23;36(35):3477-3484. Epub 2018 Oct 23.

Thomas Kaley, Lisa M. DeAngelis, Jose Baselga, and David M. Hyman, Memorial Sloan Kettering Cancer Center; Thomas Kaley, Lisa M. DeAngelis, Jose Baselga, and David M. Hyman, Weill Cornell Medical College, New York; Igor Puzanov, Roswell Park Cancer Institute, Buffalo, NY; Mehdi Touat and Antoine Hollebecque, Institut Gustave Roussy, Villejuif; Franck Bielle, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Pitié Salpêtrière-Charles Foix, Paris; Florence Joly, Centre François Baclesse, Caen; Jean-Yves Blay, Centre Léon Bérard, Lyon, France; Vivek Subbiah, MD Anderson Cancer Center, Houston, TX; Jordi Rodon, Vall d'Hebron University Hospital, Barcelona, Spain; A. Craig Lockhart, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL; Vicki Keedy, Vanderbilt University Medical Center, Nashville, TN; Ralf-Dieter Hofheinz, Universitätsmedizin Mannheim, Mannheim; Jurgen Wolf, Universitätsklinikum Köln, Cologne, Germany; Ian Chau, The Royal Marsden National Health Service Foundation Trust, London, United Kingdom; Noopur S. Raje, Massachusetts General Hospital, Boston, MA; Martina Makrutzki, F Hoffmann-La Roche, Basel, Switzerland; Todd Riehl, Genentech, South San Francisco, CA; and Bethany Pitcher, F Hoffmann-La Roche, Mississauga, Ontario, Canada.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2018.78.9990
Publisher Site
http://dx.doi.org/10.1200/JCO.2018.78.9990DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6286161PMC
December 2018

Value of low-dose whole-body CT in the management of patients with multiple myeloma and precursor states.

Skeletal Radiol 2019 May 14;48(5):773-779. Epub 2018 Sep 14.

Division of Musculoskeletal Imaging and Intervention, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Yawkey 6E, 55 Fruit Street, Boston, MA, 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00256-018-3066-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447458PMC
May 2019

Role of the RANK/RANKL Pathway in Multiple Myeloma.

Clin Cancer Res 2019 01 9;25(1):12-20. Epub 2018 Aug 9.

University of Athens School of Medicine, Athens, Greece.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-1537DOI Listing
January 2019

Panobinostat and Multiple Myeloma in 2018.

Oncologist 2018 05 14;23(5):516-517. Epub 2018 Feb 14.

Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2017-0644DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947458PMC
May 2018

Denosumab for the treatment of bone disease in solid tumors and multiple myeloma.

Future Oncol 2018 Feb 20;14(3):195-203. Epub 2017 Oct 20.

Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2017-0403DOI Listing
February 2018

Myeloma and Bone Disease.

Curr Osteoporos Rep 2017 10;15(5):483-498

Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Professional Office Building 216, 55 Fruit Street, Boston, MA, 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11914-017-0397-5DOI Listing
October 2017

Myeloma bone disease: pathogenesis and treatment.

Clin Adv Hematol Oncol 2017 Apr;15(4):285-295

Harvard Medical School, Boston, Massachusetts.

View Article

Download full-text PDF

Source
April 2017

New monoclonal antibodies on the horizon in multiple myeloma.

Ther Adv Hematol 2017 Feb 26;8(2):41-53. Epub 2016 Dec 26.

Massachusetts General Hospital, Boston, MA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/2040620716682490DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5298390PMC
February 2017

Sequencing of nontransplant treatments in multiple myeloma patients with active disease.

Hematology Am Soc Hematol Educ Program 2016 Dec;2016(1):495-503

Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA; and Harvard Medical School, Boston, MA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/asheducation-2016.1.495DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142445PMC
December 2016

Phase IB study of cabozantinib in patients with relapsed and/or refractory multiple myeloma.

Blood 2016 05 28;127(19):2355-6. Epub 2016 Mar 28.

Department of Medicine, Weill Medical College of Cornell University, New York, NY; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2016-01-694786DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5003505PMC
May 2016

Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations.

N Engl J Med 2015 Aug;373(8):726-36

From Memorial Sloan Kettering Cancer Center, New York (D.M.H., E.L.D., J.B.); Vanderbilt University Medical Center, Nashville (I.P., E.C.); University of Texas M.D. Anderson Cancer Center, Houston (V.S.); Massachusetts General Hospital, Boston (J.E.F., N.S.R.); Royal Marsden Hospital, Sutton, Surrey, United Kingdom (I.C.); Centre Léon Bérard, Lyon (J.-Y.B.), Institut Gustave Roussy, Villejuif (A.H.), Centre François Baclesse, Centre Hospitalier Universitaire Côte de Nacre, Caen (R.G.), and Institut Bergonié Cancer Center, Bordeaux (A.I.) - all in France; University Hospital of Cologne, Cologne (J.W.), Universitätsmedizin Mannheim, Mannheim (R.-D.H.), West German Cancer Center, University Hospital Essen, Essen (M.S.), and German Cancer Consortium, Heidelberg (M.S.) - all in Germany; Vall d'Hebron University Hospital and Institute of Oncology, Universitat Autònoma de Barcelona, Barcelona (M.E.E.-F., J.T.), and Hospital Universitario Madrid Sanchinarro, Madrid (M.H.) - both in Spain; and F. Hoffmann-La Roche, Basel, Switzerland (S.F.L., M.M., F.S., M.L.V.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1502309DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971773PMC
August 2015

Targeting the metabolic plasticity of multiple myeloma with FDA-approved ritonavir and metformin.

Clin Cancer Res 2015 Mar 26;21(5):1161-71. Epub 2014 Dec 26.

Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, Georgia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-1088DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5571862PMC
March 2015

Biomarkers of bone remodeling in multiple myeloma patients to tailor bisphosphonate therapy.

Clin Cancer Res 2014 Aug 23;20(15):3955-61. Epub 2014 Jun 23.

Massachusetts General Hospital Cancer Center; Harvard Medical School, Boston, Massachusetts

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-0434DOI Listing
August 2014

Advances in supportive care for multiple myeloma.

J Natl Compr Canc Netw 2014 Apr;12(4):502-11

From the aCenter for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts, and bDepartment of Medicine, Indiana University School of Medicine and the Richard L. Roudebush VA Medical Center, Indianapolis, Indiana.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.6004/jnccn.2014.0055DOI Listing
April 2014

Targeting BRAF in multiple myeloma.

Cancer Discov 2013 Aug;3(8):840-2

Massachusetts General Hospital Cancer Center, Massachusetts General Hospital, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-13-0297DOI Listing
August 2013

Denosumab, a RANK ligand inhibitor, for the management of bone loss in cancer patients.

Clin Interv Aging 2012 3;7:331-8. Epub 2012 Sep 3.

Division of Hematology-Oncology, Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/CIA.S14566DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3437759PMC
February 2013

Case records of the Massachusetts General Hospital: Case 29-2011: A 66-year-old woman with cardiac and renal failure.

N Engl J Med 2011 Sep;365(12):1129-38

Divisions of Hematology–Oncology, Massachusetts General Hospital, Boston, USA.

View Article

Download full-text PDF

Source
http://www.nejm.org/doi/10.1056/NEJMcpc1100925
Publisher Site
http://dx.doi.org/10.1056/NEJMcpc1100925DOI Listing
September 2011

Kidney disease associated with plasma cell dyscrasias.

Blood 2010 Sep 12;116(9):1397-404. Epub 2010 May 12.

Massachusetts General Hospital, Boston, 02114, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2010-03-258608DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3324369PMC
September 2010

Case records of the Massachusetts General Hospital. Case 7-2010. A 49-year-old man with peripheral neuropathy and ascites.

N Engl J Med 2010 Mar;362(10):929-40

Department of Neurology, Brigham and Women's Hospital, Boston, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMcpc0907805DOI Listing
March 2010

The monoclonal antibody nBT062 conjugated to cytotoxic Maytansinoids has selective cytotoxicity against CD138-positive multiple myeloma cells in vitro and in vivo.

Clin Cancer Res 2009 Jun 9;15(12):4028-37. Epub 2009 Jun 9.

Department of Medical Oncology, LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute Harvard Medical School, Boston, Massachusetts 02115, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-2867DOI Listing
June 2009

Case records of the Massachusetts General Hospital. Case 9-2008. A 65-year-old woman with a nonhealing ulcer of the jaw.

N Engl J Med 2008 Mar;358(12):1283-91

Department of Oral and Maxillofacial Surgery, Massachusetts General Hospital, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMcpc0800341DOI Listing
March 2008